Streptococcus Pyogenes Infection — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for streptococcus pyogenes infection. 22 active patents protecting 4 drugs from 3+ originators. First major cliff: 2030. Daily refresh.

4
Approved drugs
22
Active US patents
66/100
Avg vulnerability
—
Annual revenue covered

Originators in Streptococcus Pyogenes Infection

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Generic (originally Beecham/GSK) 14 patents AbbVie 4 patents Pfizer 3 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating streptococcus pyogenes infection. Each bar = one year. Y-axis scaled to peak year (6 patents).

3
26
1
27
1
28
6
30
2
31
6
34
2
36

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Amoxil
amoxicillin
 Generic (originally Beecham/GSK) 14 58 — 2026-12-08
Teflaro
CEFTAROLINE FOSAMIL
 AbbVie 4 61 — 2030-09-21
Cleocin T
CLINDAMYCIN PHOSPHATE
 Pfizer 3 68 — 2026-12-02
Suprax
CEFIXIME
 — 1 75 — 2028-12-14

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
8299052 Amoxil method of use 85 2027-05-07
9789057 Cleocin T method of use 80 2026-12-02
8778924 Amoxil method of use 80 2026-12-08
9233112 Suprax method of use 75 2028-12-14
11931463 Amoxil method of use 75 2034-02-12
11878011 Amoxil method of use 75 2042-05-27
8247400 Teflaro method of use 73 2031-02-10
8247400 Teflaro method of use 73 2031-02-10
11129896 Cleocin T method of use 70 2036-09-22
8357394 Amoxil formulation 65 2026-12-08

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
7977488 Amoxil composition of matter 18 2030-04-10
7977488 Amoxil composition of matter 18 2030-04-10
10238606 Amoxil formulation 42 2034-02-12
9629861 Teflaro formulation 48 2030-09-21
9629861 Teflaro formulation 48 2030-09-21
12303563 Cleocin T formulation 55 2036-09-22
9186411 Amoxil formulation 56 2030-08-11
9186411 Amoxil formulation 56 2030-08-11
9050263 Amoxil method of use 62 2034-02-12
9603806 Amoxil method of use 62 2034-02-12

Related